Intermediate phenotypes identify divergent pathways to Alzheimer's disease.

Recent genetic studies have identified a growing number of loci with suggestive evidence of association with susceptibility to Alzheimer's disease (AD). However, little is known of the role of these candidate genes in influencing intermediate phenotypes associated with a diagnosis of AD, includ...

Full description

Bibliographic Details
Main Authors: Joshua M Shulman, Lori B Chibnik, Cristin Aubin, Julie A Schneider, David A Bennett, Philip L De Jager
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-06-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2888589?pdf=render
_version_ 1811269828968710144
author Joshua M Shulman
Lori B Chibnik
Cristin Aubin
Julie A Schneider
David A Bennett
Philip L De Jager
author_facet Joshua M Shulman
Lori B Chibnik
Cristin Aubin
Julie A Schneider
David A Bennett
Philip L De Jager
author_sort Joshua M Shulman
collection DOAJ
description Recent genetic studies have identified a growing number of loci with suggestive evidence of association with susceptibility to Alzheimer's disease (AD). However, little is known of the role of these candidate genes in influencing intermediate phenotypes associated with a diagnosis of AD, including cognitive decline or AD neuropathologic burden.Thirty-two single nucleotide polymorphisms (SNPs) previously implicated in AD susceptibility were genotyped in 414 subjects with both annual clinical evaluation and completed brain autopsies from the Religious Orders Study and the Rush Memory and Aging Project. Regression analyses evaluated the relation of SNP genotypes to continuous measures of AD neuropathology and cognitive function proximate to death. A SNP in the zinc finger protein 224 gene (ZNF224, rs3746319) was associated with both global AD neuropathology (p = 0.009) and global cognition (p = 0.002); whereas, a SNP at the phosphoenolpyruvate carboxykinase locus (PCK1, rs8192708) was selectively associated with global cognition (p = 3.57 x 10(-4)). The association of ZNF224 with cognitive impairment was mediated by neurofibrillary tangles, whereas PCK1 largely influenced cognition independent of AD pathology, as well as Lewy bodies and infarcts.The findings support the association of several loci with AD, and suggest how intermediate phenotypes can enhance analysis of susceptibility loci in this complex genetic disorder.
first_indexed 2024-04-12T21:49:03Z
format Article
id doaj.art-c80ceed39c8a467d9220472695e65251
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T21:49:03Z
publishDate 2010-06-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c80ceed39c8a467d9220472695e652512022-12-22T03:15:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-06-0156e1124410.1371/journal.pone.0011244Intermediate phenotypes identify divergent pathways to Alzheimer's disease.Joshua M ShulmanLori B ChibnikCristin AubinJulie A SchneiderDavid A BennettPhilip L De JagerRecent genetic studies have identified a growing number of loci with suggestive evidence of association with susceptibility to Alzheimer's disease (AD). However, little is known of the role of these candidate genes in influencing intermediate phenotypes associated with a diagnosis of AD, including cognitive decline or AD neuropathologic burden.Thirty-two single nucleotide polymorphisms (SNPs) previously implicated in AD susceptibility were genotyped in 414 subjects with both annual clinical evaluation and completed brain autopsies from the Religious Orders Study and the Rush Memory and Aging Project. Regression analyses evaluated the relation of SNP genotypes to continuous measures of AD neuropathology and cognitive function proximate to death. A SNP in the zinc finger protein 224 gene (ZNF224, rs3746319) was associated with both global AD neuropathology (p = 0.009) and global cognition (p = 0.002); whereas, a SNP at the phosphoenolpyruvate carboxykinase locus (PCK1, rs8192708) was selectively associated with global cognition (p = 3.57 x 10(-4)). The association of ZNF224 with cognitive impairment was mediated by neurofibrillary tangles, whereas PCK1 largely influenced cognition independent of AD pathology, as well as Lewy bodies and infarcts.The findings support the association of several loci with AD, and suggest how intermediate phenotypes can enhance analysis of susceptibility loci in this complex genetic disorder.http://europepmc.org/articles/PMC2888589?pdf=render
spellingShingle Joshua M Shulman
Lori B Chibnik
Cristin Aubin
Julie A Schneider
David A Bennett
Philip L De Jager
Intermediate phenotypes identify divergent pathways to Alzheimer's disease.
PLoS ONE
title Intermediate phenotypes identify divergent pathways to Alzheimer's disease.
title_full Intermediate phenotypes identify divergent pathways to Alzheimer's disease.
title_fullStr Intermediate phenotypes identify divergent pathways to Alzheimer's disease.
title_full_unstemmed Intermediate phenotypes identify divergent pathways to Alzheimer's disease.
title_short Intermediate phenotypes identify divergent pathways to Alzheimer's disease.
title_sort intermediate phenotypes identify divergent pathways to alzheimer s disease
url http://europepmc.org/articles/PMC2888589?pdf=render
work_keys_str_mv AT joshuamshulman intermediatephenotypesidentifydivergentpathwaystoalzheimersdisease
AT loribchibnik intermediatephenotypesidentifydivergentpathwaystoalzheimersdisease
AT cristinaubin intermediatephenotypesidentifydivergentpathwaystoalzheimersdisease
AT julieaschneider intermediatephenotypesidentifydivergentpathwaystoalzheimersdisease
AT davidabennett intermediatephenotypesidentifydivergentpathwaystoalzheimersdisease
AT philipldejager intermediatephenotypesidentifydivergentpathwaystoalzheimersdisease